Artiklar med krav på offentlig åtkomst - Alessandro PulsoniLäs mer
Inte tillgängliga någonstans: 4
Comparative analysis between RQ‐PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage …
M Cavalli, LA De Novi, I Della Starza, LV Cappelli, V Nunes, A Pulsoni, ...
British Journal of Haematology 177 (4), 588-596, 2017
Krav: Government of Italy
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
M Frigeni, C Besson, C Visco, H Fontaine, M Goldaniga, M Visentini, ...
Leukemia 34 (5), 1462-1466, 2020
Krav: Agence Nationale de la Recherche, AIRC Foundation for Cancer Research in Italy
Frontline intensified ABVD demonstrates superior efficacy than PET‐adapted ABVD in advanced Hodgkin lymphoma: the FIL‐Rouge phase 3 trial by the Fondazione Italiana Linfomi
A Pinto, G Corazzelli, A Evangelista, C Patti, S De Lorenzo, A Re, F Merli, ...
Hematological Oncology 41, 31-33, 2023
Krav: Government of Italy
EARLY METABOLIC RESPONSE IN FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
S Luminari, L Guerra, R Durmo, S Chauvie, S Peano, A Franceschetto, ...
Hematological Oncology 39, 2021
Krav: Government of Italy
Tillgängliga någonstans: 20
BRAF mutations in hairy-cell leukemia
E Tiacci, V Trifonov, G Schiavoni, A Holmes, W Kern, MP Martelli, ...
New England Journal of Medicine 364 (24), 2305-2315, 2011
Krav: US National Institutes of Health
Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
E Tiacci, JH Park, L De Carolis, SS Chung, A Broccoli, S Scott, F Zaja, ...
New England Journal of Medicine 373 (18), 1733-1747, 2015
Krav: US National Institutes of Health, European Commission, Government of Italy …
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
A Gallamini, SF Barrington, A Biggi, S Chauvie, L Kostakoglu, ...
Haematologica 99 (6), 1107, 2014
Krav: Government of Italy
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial
S Galimberti, S Luminari, E Ciabatti, S Grassi, F Guerrini, A Dondi, ...
Clinical Cancer Research 20 (24), 6398-6405, 2014
Krav: Government of Italy
Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia
E Tiacci, L De Carolis, E Simonetti, M Capponi, A Ambrosetti, E Lucia, ...
New England Journal of Medicine 384 (19), 1810-1823, 2021
Krav: European Commission, Government of Italy, AIRC Foundation for Cancer …
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program
M Ladetto, C Lobetti-Bodoni, B Mantoan, M Ceccarelli, C Boccomini, ...
Blood, The Journal of the American Society of Hematology 122 (23), 3759-3766, 2013
Krav: Government of Italy
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens
D Paoli, F Rizzo, G Fiore, F Pallotti, A Pulsoni, G Annechini, F Lombardo, ...
Human reproduction 31 (2), 263-272, 2016
Krav: Government of Italy
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized …
DA Eichenauer, I Becker, I Monsef, N Chadwick, V De Sanctis, M Federico, ...
haematologica 102 (10), 1748, 2017
Krav: Cancer Research UK, UK Medical Research Council, Federal Ministry of …
Air pollution and childhood leukaemia: a nationwide case-control study in Italy
C Badaloni, A Ranucci, G Cesaroni, G Zanini, D Vienneau, F Al-Aidrous, ...
Occupational and environmental medicine 70 (12), 876-883, 2013
Krav: Government of Italy
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy
A Pulsoni, I Della Starza, LV Cappelli, ME Tosti, G Annechini, M Cavalli, ...
British Journal of Haematology 188 (2), 249-258, 2020
Krav: Government of Italy, AIRC Foundation for Cancer Research in Italy
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter …
R Bruna, F Benedetti, C Boccomini, C Patti, AM Barbui, A Pulsoni, ...
haematologica 104 (11), 2241, 2019
Krav: Government of Italy
Road traffic pollution and childhood leukemia: a nationwide case-control study in Italy
C Magnani, A Ranucci, C Badaloni, G Cesaroni, D Ferrante, L Miligi, ...
Archives of Medical Research 47 (8), 694-705, 2016
Krav: Government of Italy
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study
D Rossi, A Bruscaggin, P La Cava, S Galimberti, E Ciabatti, S Luminari, ...
haematologica 100 (4), 517, 2015
Krav: Fondazione Cariplo, Government of Italy
Mutational and immunogenetic landscape of HCV‐associated B‐cell lymphoproliferative disorders
I Defrancesco, M Visentini, S Zibellini, YA Minafò, S Rattotti, VV Ferretti, ...
American Journal of Hematology 96 (6), E210, 2021
Krav: Government of Italy, AIRC Foundation for Cancer Research in Italy
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
MS De Propris, P Musiu, S Intoppa, MG Nardacci, A Pucciarini, A Santi, ...
British Journal of Haematology 198 (2), 2022
Krav: AIRC Foundation for Cancer Research in Italy
Role of Rituximab Addition to First‐line Chemotherapy Regimens in Nodular Lymphocyte‐predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
M Gotti, R Sciarra, A Pulsoni, F Merli, S Luminari, C Zerbi, L Trentin, A Re, ...
HemaSphere 7 (4), e837, 2023
Krav: Government of Italy
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.